NEXQOVRIX Trademark

Trademark Overview


On Thursday, March 17, 2022, a trademark application was filed for NEXQOVRIX with the United States Patent and Trademark Office. The USPTO has given the NEXQOVRIX trademark a serial number of 97316940. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 23, 2026. This trademark is owned by GlaxoSmithKline Biologicals SA. The NEXQOVRIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nexqovrix

General Information


Serial Number97316940
Word MarkNEXQOVRIX
Filing DateThursday, March 17, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2026

Trademark Statements


Translation of Words in MarkThe wording NEXQOVRIX has no meaning in a foreign language.
Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Monday, March 21, 2022NEW APPLICATION ENTERED
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Saturday, December 31, 2022SUSPENSION LETTER WRITTEN
Saturday, December 31, 2022LETTER OF SUSPENSION E-MAILED
Saturday, December 31, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, July 15, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 5, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 9, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 10, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 10, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, August 9, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, May 24, 2026SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 26, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2026PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED